Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thilo Bracht

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 5, 2021
Application of SILAC Labeling in Phosphoproteomics AnalysisMarkus Stepath, Thilo Bracht
Methods in Molecular Biology (Clifton, N.J.)|May 5, 2021
Targeted Protein Quantification Using Parallel Reaction Monitoring (PRM)Katalin Barkovits, Weiqiang Chen, Michael Kohl, et al.
Biochimica Et Biophysica Acta|April 10, 2013
Label-free quantification in clinical proteomicsDominik A Megger, Thilo Bracht, Helmut E Meyer, et al.
The Biochemical Journal|July 22, 2011
Monoclonal antibodies reveal the alteration of the rhodocetin structure upon α2β1 integrin bindingThilo Bracht, Flávia Figueiredo de Rezende, Jörg Stetefeld, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 7, 2021
Quantitative analysis of proteome dynamics in a mouse model of asthmaLukas Funke, Stefanie Gnipp, Maike Ahrens, et al.
Proteomics|February 23, 2020
CalibraCurve: A Tool for Calibration of Targeted MS-Based MeasurementsMichael Kohl, Markus Stepath, Thilo Bracht, et al.
Oncotarget|June 2, 2018
Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor modelsStephan Niland, Dorde Komljenovic, Jadranka Macas, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 17, 2009
The alpha2beta1 integrin-specific antagonist rhodocetin is a cruciform, heterotetrameric moleculeJohannes A Eble, Stephan Niland, Thilo Bracht, et al.
Proteomics. Clinical Applications|June 20, 2017
Quantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinomaRaghda Saad Zaghloul Taleb, Pacint Moez, Doreen Younan, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2019
Protein Biomarker Discovery Using Human Blood Plasma MicroparticlesRaghda Saad Zaghloul Taleb, Pacint Moez, Doreen Younan, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|May 5, 2021
Application of SILAC Labeling in Phosphoproteomics AnalysisMarkus Stepath, Thilo Bracht
Methods in Molecular Biology (Clifton, N.J.)|May 5, 2021
Targeted Protein Quantification Using Parallel Reaction Monitoring (PRM)Katalin Barkovits, Weiqiang Chen, Michael Kohl, et al.
Biochimica Et Biophysica Acta|April 10, 2013
Label-free quantification in clinical proteomicsDominik A Megger, Thilo Bracht, Helmut E Meyer, et al.
The Biochemical Journal|July 22, 2011
Monoclonal antibodies reveal the alteration of the rhodocetin structure upon α2β1 integrin bindingThilo Bracht, Flávia Figueiredo de Rezende, Jörg Stetefeld, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 7, 2021
Quantitative analysis of proteome dynamics in a mouse model of asthmaLukas Funke, Stefanie Gnipp, Maike Ahrens, et al.
Proteomics|February 23, 2020
CalibraCurve: A Tool for Calibration of Targeted MS-Based MeasurementsMichael Kohl, Markus Stepath, Thilo Bracht, et al.
Oncotarget|June 2, 2018
Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor modelsStephan Niland, Dorde Komljenovic, Jadranka Macas, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 17, 2009
The alpha2beta1 integrin-specific antagonist rhodocetin is a cruciform, heterotetrameric moleculeJohannes A Eble, Stephan Niland, Thilo Bracht, et al.
Proteomics. Clinical Applications|June 20, 2017
Quantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinomaRaghda Saad Zaghloul Taleb, Pacint Moez, Doreen Younan, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 11, 2019
Protein Biomarker Discovery Using Human Blood Plasma MicroparticlesRaghda Saad Zaghloul Taleb, Pacint Moez, Doreen Younan, et al.
Pageof 6